Comprehensive genetic and mutation analysis of familial dementia with Lewy bodies linked to 2q35-q36.

The second most frequent form of neurodegenerative dementia after Alzheimer's disease is dementia with Lewy bodies (DLB). Since informative DLB families are scarce, little is presently known about the molecular genetic etiology of DLB. We recently mapped the first locus for DLB on chromosome 2q35-q36 in a multiplex Belgian family, DR246, with autopsy-proven DLB pathology in a region of 9.2 Mb. Here, we describe the ascertainment of additional DR246 family members and significant finemapping of the DLB locus to 3.3 Mb based on informative meiotic recombinants. Extensive sequencing of the 42 positional candidate genes within the DLB region did not identify a simple pathogenic mutation that co-segregated with disease in family DR246. Also high resolution analysis of copy number variations in the DLB locus did not provide evidence for a complex mutation. In conclusion, we confirmed the DLB locus at 2q35-q36 as a genetic entity but candidate gene-based sequencing and copy number variation analysis did not identify the pathogenic mutation in family DR246. Other detection strategies will be needed to reveal the underlying mutation explaining the linkage of DLB to 2q35-q26. Possibly the disease mutation in this family acts through a more complex mechanism than generally envisaged for monogenic disorders. Nevertheless, identifying the first familial DLB gene is likely to contribute an entry point into the pathogenic cascades underlying DLB pathology.

[1]  A. Miyashita,et al.  A mutant PSEN1 causes dementia with lewy bodies and variant Alzheimer's disease , 2005, Annals of neurology.

[2]  Wessel N. van Wieringen,et al.  CGHcall: Calling aberrations for array CGH tumor profiles. , 2008 .

[3]  C. Lázaro,et al.  Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations , 2009, Human mutation.

[4]  A. Singleton,et al.  alpha-Synuclein locus triplication causes Parkinson's disease. , 2003, Science.

[5]  G. Matthijs,et al.  Functional analysis of three splicing mutations identified in the PMM2 gene: Toward a new therapy for congenital disorder of glycosylation type Ia , 2009, Human mutation.

[6]  C. van Broeckhoven,et al.  Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population , 2009, Human mutation.

[7]  M. Kokai,et al.  Familial dementia with Lewy bodies (DLB). , 1999, Clinical neuropathology.

[8]  D. Campion,et al.  INTRAFAMILIAL DIVERSITY OF PHENOTYPE ASSOCIATED WITH APP DUPLICATION , 2008, Neurology.

[9]  D. Cordato,et al.  Dementia with Lewy bodies in an elderly Greek male due to α-synuclein gene mutation , 2006, Journal of Clinical Neuroscience.

[10]  K. Sleegers,et al.  Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease. , 2006, Brain : a journal of neurology.

[11]  S. Brennan,et al.  A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment , 2009, Human mutation.

[12]  T. Meitinger,et al.  A novel LRRK2 mutation in an Austrian cohort of patients with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[13]  Irene Litvan,et al.  Lrrk2 and Lewy body disease , 2006, Annals of neurology.

[14]  K. Jellinger,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. , 1996, Neurology.

[15]  K. Sleegers,et al.  Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. , 2006, American journal of human genetics.

[16]  C. Brayne,et al.  A systematic review of prevalence and incidence studies of dementia with Lewy bodies. , 2005, Age and ageing.

[17]  G. Schellenberg,et al.  Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders. , 2008, Archives of neurology.

[18]  C. Waters,et al.  Autosomal dominant Lewy body parkinsonism in a four‐generation family , 1994, Annals of neurology.

[19]  J. Trojanowski,et al.  Beta-synuclein gene alterations in dementia with Lewy bodies. , 2004, Neurology.

[20]  Douglas C. Miller,et al.  A large kindred with autosomal dominant Parkinson's disease , 1990, Annals of neurology.

[21]  K. Marder,et al.  Association of glucocerebrosidase mutations with dementia with lewy bodies. , 2009, Archives of neurology.

[22]  C. Duijn,et al.  Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression. , 2000, Human molecular genetics.

[23]  D. Dickson,et al.  A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder. , 2007, Brain : a journal of neurology.

[24]  F. Tagliavini,et al.  A novel PSEN2 mutation associated with a peculiar phenotype , 2008, Neurology.

[25]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[26]  T. Bird,et al.  Familial dementia with lewy bodies: a clinical and neuropathological study of 2 families. , 2002, Archives of neurology.

[27]  J. Hoenicka,et al.  The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.

[28]  J. Trojanowski,et al.  β-Synuclein gene alterations in dementia with Lewy bodies , 2004, Neurology.

[29]  J. Trojanowski,et al.  Glucocerebrosidase mutations are an important risk factor for Lewy body disorders , 2006, Neurology.

[30]  M. Farrer,et al.  Glucosidase-beta variations and Lewy body disorders. , 2009, Parkinsonism & related disorders.

[31]  Z. Wszolek,et al.  Familial parkinsonism, dementia, and lewy body disease: Study of family G , 1997, Annals of neurology.

[32]  C. van Broeckhoven,et al.  novoSNP, a novel computational tool for sequence variation discovery. , 2005, Genome research.

[33]  J. Morris,et al.  Familial dementia with Lewy bodies: clinicopathologic analysis of two kindreds. , 2002, Neurology.

[34]  K. Sleegers,et al.  APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. , 2006, Brain : a journal of neurology.

[35]  齋藤 和美 Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease , 2006 .

[36]  D. Cordato,et al.  Dementia with Lewy bodies in an elderly Greek male due to alpha-synuclein gene mutation. , 2006, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia.

[37]  J R O'Connell,et al.  PedCheck: a program for identification of genotype incompatibilities in linkage analysis. , 1998, American journal of human genetics.

[38]  Bassem A. Hassan,et al.  Gene prioritization through genomic data fusion , 2006, Nature Biotechnology.

[39]  J. Ott,et al.  Multilocus linkage analysis in humans: detection of linkage and estimation of recombination. , 1985, American journal of human genetics.

[40]  K. Sakai,et al.  A patient with dementia with Lewy bodies and codon 232 mutation of PRNP , 2002, Neurology.

[41]  A. Munnich,et al.  Highly conserved non-coding elements on either side of SOX9 associated with Pierre Robin sequence , 2009, Nature Genetics.